Pharming Group N.V.
$1.30▲ 0.00%(+$0.00)
TickerSpark Score
68/100
▌ Solid
70
Valuation
65
Profitability
100
Growth
76
Health
30
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PHGUF research report →
52-Week Range16% of range
Low
$1.14
Current
$1.30
High
$2.17
Company Overviewwww.pharming.com
About the company
Pharming Group N. V. operates as a biopharmaceutical firm focused on creating and commercializing protein replacement therapies and precision medicines.
- CEO
- Fabrice Chouraqui
- IPO
- 2002
- Employees
- 404
- HQ
- Leiden, NL
Price Chart
+13.04% · this period
Valuation
- Market Cap
- $918.13M
- P/E
- 72.01
- P/S
- 2.69
- P/B
- 3.88
- EV/EBITDA
- 31.25
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 88.12%
- Op Margin
- 6.36%
- Net Margin
- 3.37%
- ROE
- 4.75%
- ROIC
- 3.76%
Growth & Income
- Revenue
- $391.32M · 31.67%
- Net Income
- $2.97M · 125.05%
- EPS
- $0.00 · 124.26%
- Op Income
- $20.09M
- FCF YoY
- 2074.63%
Performance & Tape
- 52W High
- $2.17
- 52W Low
- $1.14
- 50D MA
- $1.33
- 200D MA
- $1.55
- Beta
- 0.09
- Avg Volume
- 5.75K
Get TickerSpark's AI analysis on PHGUF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · PHGUF
Our PHGUF coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on PHGUF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PHGUF report →Internal Compare
Similar companies
Peers in the same neighborhood.